AI & Analytics Consumption: Insights on Demand

Posted by Arun Shastri on Wed, Oct 02, 2019

This blog post is the fifth in a series on the impact that AI will have on different business aspects of pharma.

The past few years have seen an explosion of data, and with it, the need to make use of it. Gathering and stitching together internal and external data sources presents one set of challenges, but what about the analysts who struggle to leverage all of this data? How can they keep up with increasing demands for data-driven insights from the entire organization? How can we empower the whole organization to have access to these critical insights? Here’s a hint: AI is part of the solution.


>
Read More

AI & Clinical Trials: Poised for Disruption

Posted by Arun Shastri on Wed, Sep 11, 2019

This blog post is the third in a series on the impact that AI will have on different business aspects of pharma.

We always tell our clients to start small with AI. As Pratap Khedkar shared in my first interview, it’s important to start with clear, specific use cases. For some aspects of the business, it may take some time to carefully consider what these specific use cases are and what opportunities AI can create. Clinical trials present no such difficulties. The opportunities to improve efficiencies are numerous and clear, and AI has begun to make an impact. The industry is aware of the inefficiencies that abound in clinical trial design and execution and is eager to solve them.


>
Read More

AI & Pharma: Start Small But Think Big

Posted by Arun Shastri on Wed, Jul 24, 2019

This blog post is the first in a series on the impact that AI will have on different business aspects of pharma.

AI has been here for many decades, but the buzz around this latest wave of AI is louder than any I can remember. You can find articles about AI in every publication and medium. These articles deal mostly with broad themes, rarely delving into how AI might be applied in our work lives. There are plenty of stories about self-driving cars and the latest human expert to be outwitted by an algorithm. But what about the unsexy business that most of us find ourselves in? How can we apply AI to improve customer interactions, maximize product launches, optimize clinical trial operations, or find patient insights?


>
Read More

Launching Conversational AI: Six Keys to Success

Posted by Satish Jha on Tue, Jul 16, 2019

Vaibhav Bansal co-wrote this post with Satish Jha 

A witty, ever-reliable butler is a must-have for crime-fighting billionaires — just ask Bruce Wayne. The closest thing that Tony Stark has to a butler is his AI assistant Jarvis, with its alert, intelligent and unaffected responses to Ironman’s perpetual snark.

While we are still years away from creating a chat bot as sophisticated as Jarvis, the recent advancements in NLP, (natural language processing, the technology that powers chat bots,) have been very encouraging. Someday, we believe these AI agents will become so advanced that they allay the common belief that AI can’t be as perceptive or intuitive as humans. Though such a future is a few decades away, conversational AI is already solving countless problems and driving better engagement and experience.


>
Read More

Putting Agile Launch Into Practice

Posted by Ben Hohn on Wed, Mar 27, 2019

Judith Kulich, Mike Kelly, Christina Corridon, Mary Ann Godwin and Kapila Viges co-wrote this blog post with Ben Hohn.

Most large pharma and biotechnology companies have historically relied on a singular "best practice model" for preparing for launch. Highly structured and rigid launch readiness models made sense in a world where similarities between launches were significant. As pipelines and portfolios have evolved dramatically—now reflecting launches in specialty, rare disease, combination therapies, personalized medicine, and follow-on indications instead of mass-market blockbusters—a rigid, one-size-fits-all model for launch excellence isn’t sufficiently relevant for each launch. A new launch excellence model that’s more agile, flexible and reflective of the varied launches that a company faces should be the goal.


>
Read More